Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lung Neoplasms × monalizumab × Clear all

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Head and Neck Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Laryngeal Diseases 1

Interventions

Carboplatin 84 pembrolizumab 61 Pemetrexed 61 Cisplatin 55 Paclitaxel 46 Docetaxel 45 Gemcitabine 30 Erlotinib Hydrochloride 22 Nivolumab 21 osimertinib 14 durvalumab 14 Cetuximab 12 130-nm albumin-bound paclitaxel 12 Bevacizumab 11 Gefitinib 10 Etoposide 10 Drug Therapy 10 Injections 9 Radiotherapy 8 Ipilimumab 8 Albumin-Bound Paclitaxel 8 Vinorelbine 7 epacadostat 6 capmatinib 6 Taxes 6 motexafin gadolinium 5 ceritinib 5 atezolizumab 5 Fluorouracil 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05061550 2026-03-11

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡